UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by SeaCrest Wealth Management LLC
SeaCrest Wealth Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,857 shares of the healthcare conglomerate’s stock after acquiring an additional 89 shares during the period. SeaCrest Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,703,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC grew its position in UnitedHealth Group by 0.6% in the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock valued at $18,433,841,000 after buying an additional 295,642 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of UnitedHealth Group by 5.2% during the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after purchasing an additional 569,142 shares in the last quarter. Morgan Stanley boosted its position in shares of UnitedHealth Group by 4.9% during the 3rd quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock valued at $2,183,416,000 after purchasing an additional 325,936 shares in the last quarter. Sanders Capital LLC boosted its position in shares of UnitedHealth Group by 3.3% during the 3rd quarter. Sanders Capital LLC now owns 5,600,237 shares of the healthcare conglomerate’s stock valued at $1,927,739,000 after purchasing an additional 178,100 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of UnitedHealth Group by 2.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,893,662 shares of the healthcare conglomerate’s stock valued at $1,525,698,000 after purchasing an additional 99,425 shares in the last quarter. 86.03% of the stock is currently owned by institutional investors and hedge funds.
Several research firms have recently weighed in on UNH. Truist raised their price objective on shares of UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. BMO Capital Markets raised their price objective on shares of UnitedHealth Group from $385.00 to $395.00 and gave the company a “market perform” rating in a research report on Wednesday, December 2nd. They noted that the move was a valuation call. Bank of America reiterated a “buy” rating and issued a $415.00 target price on shares of UnitedHealth Group in a report on Thursday, January 21st. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $355.00 to $395.00 and gave the stock an “average” rating in a report on Thursday, November 5th. Finally, Piper Sandler raised their target price on shares of UnitedHealth Group from $385.00 to $409.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. Five research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $387.82.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, beating the consensus estimate of $2.39 by $0.13. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The company had revenue of $65.47 billion for the quarter, compared to the consensus estimate of $64.98 billion. During the same quarter last year, the company posted $3.90 earnings per share. The company’s revenue for the quarter was up 7.5% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.
In other UnitedHealth Group news, Director Richard T. Burke sold 7,000 shares of the stock in a transaction that occurred on Tuesday, December 8th. The stock was sold at an average price of $349.78, for a total transaction of $2,448,460.00. Following the transaction, the director now owns 159,487 shares in the company, valued at $55,785,362.86. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the sale, the chief accounting officer now owns 31,908 shares in the company, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 37,293 shares of company stock worth $12,886,401. Corporate insiders own 0.80% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Further Reading: Monthly Dividend Stocks Can Provide Solid Income
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.